Home Rock News Megadeth’s Dave Mustaine Diagnosed With Throat Cancer

Megadeth’s Dave Mustaine Diagnosed With Throat Cancer

Megadeth’s Dave Mustaine Diagnosed With Throat Cancer

Megadeth Dave Mustaine
Megadeth [Matt Bishop Photo for The Rock Revival]
(TRR) – Megadeth frontman Dave Mustaine has been diagnosed with throat cancer. The thrash guitar icon revealed the news on Monday in a post on his official social media accounts. According to Mustaine, he has already begun a treatment plan that has a 90% success rate.

“I’ve been diagnosed with throat cancer. It’s clearly something to be respected and faced head on – but I’ve faced obstacles before. I’m working closely with my doctors, and we’ve mapped out a treatment plan which they feel has a 90% success rate. Treatment has already begun. Unfortunately, this requires that we cancel most shows this year. The 2019 Megacruise will happen, and the band will be a part of it in some form. All up to date information will be at megadeth.com as we get it. Megadeth will be back on the road ASAP. Meanwhile, Kiko, David, Dirk and I are in the studio, working on the follow up to Dystopia – which I can’t wait for everyone to hear. I’m so thankful for my whole team – family, doctors, band members, trainers, and more. I’ll keep everyone posted.

See you soon,
Dave Mustaine”

Megadeth’s MegaCruise will set sail on October 13, 2019 in the Pacific out of Los Angeles, CA aboard the Norwegian Jewel. The ship will make stops in San Diego, CA and Ensenada, Mexico. Confirmed acts for the floatin festival include Anthrax, Testament, Corrosion of Conformity, Suicidal Tendencies, Dragonforce, Overkill, DevilDriver, Doro, Armored Saint, John 5, Phil Cambell & The Bastard Sons, Metal Church, Danko Jones, Beasto Blanco, and more.

Megadeth’s last album – 2016’s Dystopia – peaked at No. 3 on the Billboard Top 200. The title track earned the band the GRAMMY Award for Best Metal Performance. It is the band’s first GRAMMY Award win.

Megadeth are currently in the studio working on a brand new album.